Is Eli Lilly and Company (LLY) the Best Low Volatility Stock to Buy Now?

From Yahoo Finance: 2025-04-19 15:09:00

The US stock market faced a turbulent first quarter of 2025 with increased volatility and negative returns. Uncertainty surrounding tech stocks, economic data, and trade tensions caused market fluctuations.

An AI software from China named DeepSeek rivaled US competitors, leading to a global investor sell-off. The US imposed tariffs against Chinese tech firms to mitigate the impact of DeepSeek.

Interest rates added to market volatility, with the Federal Reserve maintaining rates between 4.25% and 4.50%. The US economy is facing stagflation, with the Cboe Volatility Index currently at 32.64%.

Investors are leaning towards low-risk stocks amidst market volatility. Low-volatility stocks are outperforming the market in 2025, with hedge fund managers recommending them as a safe haven during uncertain times.

Eli Lilly and Company (LLY) is a global pharmaceutical company with a 5-Year Monthly Beta of 0.5 and 115 hedge fund holders. LLY focuses on discovering, developing, and marketing human pharmaceuticals across various therapeutic areas.

LLY has made strategic acquisitions and signed agreements to drive growth. Its recent success with a Phase 3 trial for orforglipron, a GLP-1 medication, has boosted investor confidence in the company’s competitive position in the obesity drug market.

Despite LLY ranking 4th on the low volatility stocks list, the potential of AI stocks for higher returns is highlighted. An AI stock has shown promise in 2025, outperforming popular AI stocks. Investors seeking high returns can explore AI stocks trading at a discount.



Read more at Yahoo Finance: Is Eli Lilly and Company (LLY) the Best Low Volatility Stock to Buy Now?